Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07756671
PHASE1

Photodynamic Therapy For Onychomycosis

Sponsor: The University of Texas Health Science Center, Houston

View on ClinicalTrials.gov

Summary

The purpose of this study is clinical and mycological clearance of onychomycosis using photodynamic therapy (PDT) with aminolevulinic acid (ALA) 10% gel at 6 months, 3 months, 9 months and 12 months

Official title: Photodynamic Therapy For Onychomycosis: An Open Label Study

Key Details

Gender

All

Age Range

18 Years - 100 Years

Study Type

INTERVENTIONAL

Enrollment

5

Start Date

2026-08-10

Completion Date

2027-12-31

Last Updated

2026-08-11

Healthy Volunteers

No

Interventions

DRUG

ALA 10% gel

ALA 10% gel will be applied under occlusion for 3 hours before PDT

DEVICE

PDT

Participants will have illumination on the affected nail with RhodoLED® XL 635 nm red light at 37 J/cm² at 5 inches for 13.5 minutes.

DRUG

Urea

Participants will have 20% urea applied to affected nail daily for 2 weeks before start of treatment

Locations (3)

Arlington Center for Dermatology

Arlington, Texas, United States

Houston Skin

Houston, Texas, United States

Houston Skin

Webster, Texas, United States